-
[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)
-
Cy3.5 NHS ester,95%, 25mg
-
[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)
phenyl]
phenylmethyl]-N,2-dimethyl-2-propanesulfinamide,95%, 5mg
-
[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)
phenyl]
phenylmethyl]-N,2-dimethyl-2-propanesulfinamide,95%, 25mg
-
(S)-3-(tert-Butyl)-4-(2,6-dimethoxy
phenyl)-2,2-dimethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole,97%, ≥99%ee, 500mg
-
Cy3.5 NHS ester,95%, 1mg
-
Cy3.5 NHS ester,95%, 5mg
-
(4-Chloro-3-methyl-
phenyl)-hydrazine hydrochloride,95%, 1g
-
(S)-3-(tert-Butyl)-4-(2,6-dimethoxy
phenyl)-2,2-dimethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole,97%, ≥99%ee, 25mg
-
(S)-3-(tert-Butyl)-4-(2,6-dimethoxy
phenyl)-2,2-dimethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole,97%, ≥99%ee, 100mg
-
(2R,2’S,3R,3’R)-3,3′-di-tert-butyl-2,2′-diisopropyl-2,2’,3,3′-tetrahydro-4,4′-bibenzo[d][1,3]oxaphosphole,≥97%, ≥99%ee, 100mg
-
2-METHYLVALERIC ACID,≥95%, 250mg
стр.: